Trials / Active Not Recruiting
Active Not RecruitingNCT03030066
Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas
A Phase 1 Study of DS-1001b in Patients With IDH1 Mutated Gliomas
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and anti-tumor activity of DS-1001b in patients with gliomas that harbor IDH1-R132 mutations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DS-1001b | Generic not assigned |
Timeline
- Start date
- 2017-01-19
- Primary completion
- 2021-01-31
- Completion
- 2026-08-31
- First posted
- 2017-01-24
- Last updated
- 2026-02-04
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03030066. Inclusion in this directory is not an endorsement.